The Venous Thrombotic Risk in Nonsurgical Patients
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 52 (7) , 16-29
- https://doi.org/10.2165/00003495-199600527-00005
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseasesThe Lancet, 1996
- Prevention of Venous Thromboembolic Risk in Non-Surgical PatientsPathophysiology of Haemostasis and Thrombosis, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Results of the seven-year prospective study of stroke patients.Stroke, 1988
- Risk factors for pulmonary embolismThe American Journal of Medicine, 1983
- Low dose heparin in the prevention of deepvein thromboses in patients with acute myocardial infarctionAmerican Heart Journal, 1980
- Identifying patients at risk for thromboembolism. Use of 125I-labeled fibrinogen in patients with acute myocardial infarctionJAMA, 1976
- LOW-DOSE HEPARIN AFTER MYOCARDIAL INFARCTIONThe Lancet, 1972